Explore all the latest information in
, arranged by key congresses and meetings. Listed below are recently updated congresses and meetings.
Is arsenic trioxide effective in treating aGvHD? Results from an in vitro study
Xiao Liu and colleagues conducted a preclinical study to investigate the role of macrophage polarization in aGvHD and...
Can ruxolitinib be safely combined with regulatory T cells to enhance efficacy in treating cGVHD?
Virginia Escamilla Gómez and colleagues conducted a study to investigate whether adding Tregs to...
ALPHA study: First-in-human data of ALLO-501 and ALLO-647 in R/R large B-cell or follicular lymphoma
During the American Society of Clinical Oncology (ASCO) Annual Meeting, the GvHD Hub was pleased to...
July 2019 | Conditioning regimens for stem cell transplantation in GvHD
Conditioning regimens are an essential part of stem cell transplantation, and so the GvHD Hub is focusing on education...
COVID-HEME forum supports hematologists during COVID-19 pandemic
Philippe Armand and Roch Houot share information related to the recently launched COVID-HEME initiative including how hematologists can...
Summary of TCT 2020 highlights – GvHD prophylaxis
An overview of the International Academy for Clinical Hematology webinar was delivered by Bipin Savani on April 1, 2020. It is the third in a series...
Editorial Theme | Novel therapies for the treatment of GvHD
Currently, there are only two approved treatments for GvHD: ruxolitinib, indicated for steroid resistant (SR) aGvHD, and ibrutinib, used in...
Monthly Theme | Predictive factors for GvHD
This month, the GvHD Hub are focusing on prognostic factors for Graft-versus-Host Disease (GvHD).
American Association for Cancer Research
American Society of Clinical Oncology
American Society of Hematology
European Hematology Association
European Society for Blood and Marrow Transplantation
EBMT GvHD Summit 2019
International Academy for Clinical Hematology
ASTCT and CIBMTR TCT Meeting 2019
ASTCT and CIBMTR TCT Meeting 2020